Thämmig V R, Godehardt E, Friedrich M, Herrmann H
Abteilung für Radiologie und Nuklearmedizin, St.-Clemens-Hospital, Geldern.
Rofo. 1993 Jan;158(1):62-6. doi: 10.1055/s-2008-1032603.
Over a period of twelve years we have performed 793 parasternal lymphoscintigrams with microcolloids in 272 patients with unilateral carcinoma of the breast. In 173 patients we were able to follow their course with an average of four examinations and an average period of observation of 48 months. The parasternal lymph nodes could be identified in 59.6% (on the side of the tumour in 55.1%, on the contralateral side in 64.2%). Expressed as an index with maximal value of 1, the (non-)demonstration constant was 0.79 (side of the tumour 0.78, opposite side 0.80). Comparison of the total scans with the initial findings showed general loss of scintigraphic uptake which, however, is not reflected during individual ICR localisation. Patients with the highest prevalence of parasternal metastases showed atypical uptake. There was no change in uptake in those patients who subsequently developed distant metastases.
在12年的时间里，我们对272例单侧乳腺癌患者进行了793次使用微胶体的胸骨旁淋巴闪烁扫描。在173例患者中，我们能够对其病程进行随访，平均进行4次检查，平均观察期为48个月。胸骨旁淋巴结在59.6%的患者中可以被识别（肿瘤侧为55.1%，对侧为64.2%）。以最大值为1的指数表示，（未）显示常数为0.79（肿瘤侧为0.78，对侧为0.80）。将全部扫描结果与初始结果进行比较，发现闪烁扫描摄取普遍减少，然而，在个体术中放射治疗（ICR）定位过程中并未体现出来。胸骨旁转移发生率最高的患者表现出非典型摄取。在随后发生远处转移的患者中，摄取情况没有变化。
